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Distribution of depression, 
somatization and pain-related 
impairment in patients with chronic 
temporomandibular disorders
Objective: the aim of this study was to describe the frequency of 
psychosocial diagnoses in a large sample of patients attending a tertiary 
clinic for treatment of temporomandibular disorders (TMD). Material and 
Methods: six hundred and ninety-one patients who sought treatment for pain-
related TMD were selected. Chronic pain-related disability (Graded Chronic 
Pain Scale, GCPS), depression [Symptoms Checklist-90 (SCL-90) scale for 
depression, DEP] and somatization levels (SCL-90 scale for non-specific 
physical symptoms, SOM) were evaluated through the Research Diagnostic 
Criteria for TMD (RDC/TMD) Axis II psychosocial assessment; TMD diagnoses 
were based on the Axis I criteria. Results: the majority of patients presented 
a low disability or no disability at all, with only a small portion of individuals 
showing a severely limiting, high disability pain-related impairment (4.3%). 
On the other hand, abnormal scores of depression and somatization were 
high, with almost half of the individuals having moderate-to-severe levels 
of depression and three-fourths presenting moderate-to-severe levels of 
somatization. The prevalence of high pain-related disability (GCPS grades 
III or IV), severe/moderate depression and somatization was 14.3%, 44% 
and 74.1% respectively. Gender differences in scores of SCL-DEP (p=0.031) 
and SCL-SOM (p=0.001) scales were signficant, with females presenting 
the highest percentage of abnormal values. Conclusion: patients with TMD 
frequently present an emotional profile with low disability, high intensity 
pain-related impairment, and high to moderate levels of somatization and 
depression. Therefore, given the importance of psychosocial issues at the 
prognostic level, it is recommended that clinical trials on TMD treatment 
include an evaluation of patients’ psychosocial profiles.
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Introduction
Several studies have reported that patients with 
chronic pain conditions show high psychosocial 
impairment compared with pain-free control groups.1,2 
These psychosocial variables are associated with 
poorer pain-related adjustment among patients with 
chronic pain.3 Similar results have also been reported 
for patients with painful temporomandibular disorders 
(TMD) (i.e., myofascial pain, arthralgia, arthritis), who 
showed higher psychosocial impairment than TMD-free 
individuals.4,5
Based on such observations, theories on the 
etiology of TMDs and its implications for treatment 
have progressively embraced the importance 
of a comprehensive biological and psychosocial 
assessment6 and TMDs are now viewed as a complex 
disorder resulting from an interplay of causes, 
including multiple genetic and environmental 
domains.7 Psychological impairment is associated 
with greater severity and persistence of TMD-related 
clinical symptoms,7 which affect approximately 10% of 
the population, with a higher prevalence in females.8
The  Resea r ch  D i agnos t i c  C r i t e r i a  f o r 
Temporomandibular Disorders (RDC/TMD) Axis II9 
was specifically designed for a thorough psychosocial 
assessment, allowing evaluation of the severity 
of chronic pain and the levels of depression and 
somatization in TMD patients. The revised and updated 
version, now called Diagnostic Criteria for TMD (DC/
TMD),10 widened the usefulness of the instruments to 
the clinical setting, thanks to a refinement of Axis I 
(i.e., physical) algorithms and the addition of some 
Axis II measures. Nonetheless, the core features of 
the original Axis II that have been used for years to 
collect psychosocial data on TMD patients as part of 
the RDC/TMD guidelines are still useful tools to share 
epidemiological data among the different research 
groups, as well as to characterize behavioral features 
in clinical settings.
In the light of recent observations that only a few 
articles have reported Axis II findings, basically limiting 
the construct of a biopsychosocial model for pain, 
further studies are required to improve the knowledge 
on the epidemiology and prevalence of psychosocial 
factors in TMD patients.11,12 Based on that, multicenter 
studies have been performed to depict the frequency 
of Axis II findings in TMD patients.13 The absence 
of correlation between Axis I, i.e. the diagnoses of 
TMD physical symptoms, and Axis II, i.e. the level of 
psychological and pain-related impairment, has been 
reported.14 Moreover, treatment-seeking behavior 
seems to be the discriminant factor to differentiate 
patient and non-patient populations, and psychosocial 
factors emerged as the main predictor of treatment 
outcome.15
Considering these drawbacks, the paucity of 
epidemiological data on Axis II is still evident in the 
TMD literature. Therefore, the aim of this study was 
to describe the frequency of psychosocial diagnoses 
in a large sample of patients attending a tertiary TMD 
clinic to provide an epidemiological basis for future 
comparisons.
Material and methods
Study population
A total of 691 patients (571 women, 120 men; 
mean age: 42.5 years, range: 18 to 61 years) who 
sought treatment at the TMD Clinic, Department of 
Maxillofacial Surgery, University of Padova, Italy, from 
2011 to 2015 for pain-related TMD were selected. 
Exclusion criteria were age less than 18, diagnosis 
of other orofacial pain disorders, and presence of 
polyarthritis and/or other rheumatic disease.
Assessment instruments
Complete examination was carried out according 
to the Italian version of the RDC/TMD protocol (RDC/
TMD Consortium Network). Psychosocial status was 
assessed by the Axis II questionnaire, which contains 
specific items for the appraisal of chronic pain severity 
and of subjective signs and symptoms for levels of 
depression and somatization.9
The Graded Chronic Pain Scale (GCPS)16 allows the 
categorization of pain patients into five levels of pain-
related impairment (from 0: no TMD pain in the prior 
6 months, to IV: high disability, severely limiting); 
while the Depression and Somatization scales of the 
Symptom Checklist 90R (SCL-90R), SCL-DEP and SCL-
SOM, respectively,17 categorized patients within three 
groups as normal, moderate, or severe levels.
The frequencies of the different scores for the 
GCPS, SCL-DEP, and SCL-SOM in the study population 
were reported by descriptive analysis. Analysis of 
variance (ANOVA) test was used for age differences 
between patients with different Axis II ratings, and 
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chi-squared test was used for gender comparisons.
All patients gave their written informed consent 
to the clinical diagnostic procedures undertaken 
during the investigation, and the study protocol was 
approved by the University of Padova’s Institutional 
Review Board.
Results
GCPS scores showed that most patients were rated 
as grade I or II, with 42.0% having low disability but 
high intensity pain-related impairment. Conversely, 
only 7.9% of patients reported no disability at all 
(grade 0), and 4.3% showed severely limiting, high 
disability (grade IV) (Table 1).
Approximately 74.1% of patients showed abnormal 
values on the SCL-SOM scale, indicating severe 
(50.9%) or moderate (23.2%) somatization levels. 
As for the SCL-DEP scale, the percentage of patients 
with abnormal values was lower (41.0% severe, 3.0% 
moderate) (Table 2).
Age differences between patients with different 
Axis II scores were not significant (GCPS, p=0.769; 
SCL-SOM, p=0.592; SCL-DEP, p=0.707). Gender 
differences in scores of SCL-DEP (p=0.031) and SCL-
SOM (p=0.001) scales were signficant, with females 
presenting the highest percentage of abnormal values. 
Females had the highest frequency of high pain-related 
impairment (15.2%) in the GCPS scores, even though 
most female individuals presented low disability, high 
intensity pain-related impairment (42.7%) (Table 3). 
Likewise, females presented the highest frequency 
of severe impairment in the SCL-DEP and SCL-SOM 
scales, with 42.6% and 53.4% respectively (Table 4).
Discussion
The importance of assessing psychosocial factors 
in TMD patients has been recognized in the literature, 
which showed an association between TMD pain 
and psychological symptoms including depression, 
somatization, and anxiety.6,14 To address this issue, the 
standardized guidelines of RDC/TMD Axis II provide 
useful assessment tools for psychosocial appraisal of 
TMD patients and for rating of pain-related impairment, 
i.e. disability and limitations in an individual’s everyday 
life.9 Notwithstanding, only few studies addressed the 
issue of psychosocial disorders in TMD patients and 
focused on the description of the entire spectrum of 
symptoms included in the Axis II evaluation, i.e. both 
the rating of pain-related impairment and the levels of 
depression and somatization. This is important in the 
light of the recently described absence of correlation 
between physical (i.e., Axis I) and psychosocial 
GCPS Categories (%)
No disability 7.9
Low disability, low intensity (grade I) 35.4
Low disability, high intensity (grade II) 42
High disability, moderately limiting (grade III) 10.2
High disability, severely limiting (grade IV) 4.3
GCPS: Graded Chronic Pain Scale
Table 1- Distribution of GCPS ratings
SCL-DEP SCL-SOM
Normal 56% 25.8%
Moderate 3% 23.2%
Severe 41% 50.9%
SCL-DEP: Symptom Checklist 90R - Depression; SCL-SOM: 
Symptom Checklist 90R - Somatization
Table 2- Percentage of patients receiving different scores in the 
Research Diagnostic Criteria for Temporomandibular Disorders 
(RDC/TMD) Axis II Depression (SCL-DEP) and Somatization 
(SCL-SOM) scales
GCPS Scales Female 
(%)
Male 
(%)
No disability 7.5 10
Low disability, low intensity (grade I) 34.5 40
Low disability, high intensity (grade II) 42.7 38.3
High disability, moderately limiting (grade III) 10.6 8.3
High disability, severely limiting (grade IV) 4.5 3.3
GCPS: Graded Chronic Pain Scale. *p<0.05 for abnormal values
Table 3- Percentage of genders according to GCPS category
Female (%) Male (%)
SCL-DEP Normal 55 61.7
Moderate 2.4* 5.8
Severe 42.6* 32.5
SCL-SOM Normal 23.3 38.3
Moderate 23.3* 23.3
Severe 53.4* 38.3
SCL-DEP: Symptom Checklist 90R - Depression; SCL-SOM: 
Symptom Checklist 90R - Somatization. * p<0.05 for abnormal 
values
Table 4- Percentage of genders allocated according to the 
severity of Depression (SCL-DEP) and Somatization (SCL-SOM) 
scales
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findings (i.e., Axis II) with the latter, rather than the 
former, being the key issue to predict the treatment 
outcome.14,15 Thus, approaching TMD epidemiology 
without taking into account the Axis II limits the 
construct of the so-called biopsychosocial model of 
pain.11 Therefore, this large-sample investigation 
reports Axis II findings in a population of TMD patients 
attending a tertiary clinic to provide a framework for 
clinicians who could expect patients with different 
ratings of psychosocial impairment, regardless of the 
Axis I diagnoses.
In this investigation, based on GCPS scores, the 
frequencies of the most severe degrees of pain-
related impairment were 10% for grade III and 4.3% 
for grade IV. Available data on the different GCPS 
categories reported prevalence of 3.1% and 6.3% 
of high intensity, severely and moderately limiting 
pain respectively,18 which is similar to the findings 
of this study. This investigation is also in line with 
other three studies reporting a range of 13% to 
21.8% for the two most severe GCPS ratings.5,7,14 This 
variability of results is likely reflecting differences in 
patient samples, possibly due to strategies of patient 
recruitment and referral as well as cultural attitudes 
towards treatment-seeking behavior. Notwithstanding, 
it can be confirmed that a minority of patients with 
TMDs reported high pain-related impairment, and 
only a very small proportion (4.3% in the present 
investigation) developed such highly disabling pain 
leading to severe limitation.
The importance of assessing the levels of pain 
intensity and pain-related disability evaluated by the 
GCPS lies in its influence on the clinical decision-making 
process, i.e. knowing or not such profile is emerging as 
a factor that affects the prognosis of TMD symptoms. 
In short, it can be suggested that patients with severe 
impairment are the worst treatment responders, while 
those with low impairment seem to have benefit even 
from “simple” cognitive-behavioral therapy regimen 
and may take advantage of the positive natural 
variation of symptoms.14,15,19 In addition, the GCPS 
has been used to identify groups of patients that may 
benefit more from cognitive-behavioral approaches.20 
Thus, it is quite surprising that the number of research 
on pain-related impairment in TMD patients is not 
relevant; also, the increase in the diffusion of GCPS 
in both research and clinical settings is strongly 
recommended to aid the selection of an appropriate 
treatment protocol including tailored strategies to 
address pain-related impairment.21 Lack of Axis II 
records and/or inappropriate interpretation of Axis II 
findings is a shortcoming that negatively affects the 
definition of management strategies in clinical settings.
As for the SCL-90R scores, moderate to severe 
levels of depression and somatization were detected 
in 44% and 74.1% of patients, respectively. These 
findings are similar to available data in which the 
prevalence of depression and somatization was 
49% and 69% respectively;4 and with data reported 
by other research groups who conducted similar 
investigations.22-24 Based on all these data, it could 
be suggested that the association between TMD 
and psychosocial factors is part of a more complex 
pain-psychopathology association, including at least 
symptoms of depression and somatization
In TMD patients, somatization severity has been 
useful to distinguish the perception of the physical 
intensity of pain, and to evaluate its cognitive and 
emotional meaning. In addition, several studies 
have found a relationship between measures for 
somatization and clinical pain in populations with 
chronic pain, including chronic TMD patients. 
In particular, somatization is related to a more 
widespread pain,25,26 with the number of coexisting 
chronic pain conditions,25 with complaint of symptoms 
in the absence of organic disease,27 and with TMD 
treatments outcomes.28
Similarly, depression in chronic TMD populations 
has been associated with several reported pain 
conditions,29 treatment outcomes, altered pain 
perception and thresholds.30 There is considerable 
comorbidity between the clinical characteristics of 
affective and somatoform disorders, since many 
criteria that are associated with depression involve 
bodily symptoms, behavioral avoidance, and appraisal 
of events as threatening, thus also being potential 
signs of somatization.
Selecting behavioral treatments based on 
psychosocial profiles was shown to be successful in 
TMD patients,20,28,31 due to the non-negligible portion of 
individuals with Axis II disorders and their consequent 
influence on treatment outcomes. Therefore, it is 
possible that treatment effects for a depressed 
patient could be enhanced in a different way than for 
a somatically focused patient by targeting passive 
behavioral responses to pain and training patients in 
behavioral and self-regulation exercises, respectively.32 
Therefore, these findings suggest that, due to the 
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influence of psychosocial factors, clinical trials should 
consider different types of treatment protocols based 
also on the psychosocial profile of patients.
This study also assessed the gender distribution 
of TMD diagnoses regarding Axis II findings. 
Gender-stratified distribution showed that females 
presented the highest scores in all three Axis II 
scales for abnormal values. This result is similar to 
that reported in a sample of Asian TMD patients,22 
in which the prevalence of females with abnormal 
values in the three scales was higher compared to 
males. Conversely, Rantala33 (2004) reported similar 
abnormal scores between females and males in 
the depression and somatization scales, which is in 
contrast with the present findings. Therefore, it is 
cautionary to suggest that further research is needed 
to explore how differences in gender, culture, ethnicity, 
and variations in healthcare provision are possible 
factors influencing the differential expression of TMD 
in patients around the world.
This investigation has some shortcomings that 
could be addressed in future studies. The main 
limitation is the absence of information on the Axis I 
diagnosis, which might have given a more complete 
clinical picture. On the other hand, the absence 
of correlation with the psychosocial findings has 
already been shown,14 and Axis II is emerging as 
the most important outcome predictor for treatment 
purposes.15,21 As a further note, the inclusion of 
TMD-free control groups could impact the relative 
importance of psychosocial impairment in TMD patients 
with respect to the general population, but it should be 
remarked that previous case-control studies support a 
higher Axis II impairment in TMD patients.4 Moreover, 
despite all aforementioned statements about the TMD-
psyche relationship and usefulness of the RDC/TMD 
Axis II scales for the evaluation of depression and 
somatization symptoms,26 it must be remarked that 
they provide an assessment of clinical characteristics 
and are not diagnostic of any psychopathology. Based 
on that, the inclusion of psychologists in the team 
of caregivers is recommended when such screening 
tools identify severe Axis II symptoms. Finally, future 
investigations using the DC-TMD and the additional 
Axis II tools will help to assess the psychosocial profile 
of TMD patients in a more comprehensive way.
Thus, to our knowledge, this investigation 
presented the largest Axis II data collection in a TMD 
population for future comparison. Methodological 
issues concerning the size and representativeness 
(e.g. type of TMD, pain duration) of the study 
population should be considered for refinement and 
comparison with future investigations.
Conclusions
Based on our findings, it can be concluded that 
patients with TMD frequently present an emotional 
profile with low disability, high intensity pain-related 
impairment and with high to moderate levels of 
somatization and depression. Given the importance 
of psychosocial issues at the prognostic level, it is 
recommended that these data are taken as reference 
standpoint for future comparisons and that clinical 
trials on TMD treatment include an evaluation of 
patients’ psychosocial profiles in order to identify pain 
phenotypes related to the TMD manifestation.
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